Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 17.05
-11.4 %
$ 492 M
Market Cap
26.81
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Castle Biosciences, Inc.
| Net Income | 18.2 M |
| Depreciation & Amortization | 16 M |
| Capital Expenditures | -28.3 M |
| Stock-Based Compensation | 50.3 M |
| Change in Working Capital | -14.1 M |
| Others | -3.89 M |
| Free Cash Flow | 36.5 M |
Cash Flow
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||
| Net Income | 18.2 | (57.5) | (67.1) | (31.3) | (10.3) | 5.3 | (6.4) | (12.4) |
| Depreciation & Amortization | 16.0 | 12.3 | 10.5 | 3.4 | 0.5 | 0.4 | 0.3 | 0.3 |
| Deferred Income Tax | 1.4 | (0.2) | (1.9) | (8.7) | 1.4 | (2.3) | 0.3 | (0.2) |
| Stock Based Compensation | 50.3 | 51.2 | 36.3 | 21.7 | 8.3 | 1.2 | 0.3 | 0.1 |
| Other Operating Activities | (7.0) | (4.9) | (19.5) | 33.0 | 0.8 | 2.4 | 0.5 | 0.5 |
| Change in Working Capital | (14.1) | (6.6) | 7 K | (4.1) | 9.1 | 44 K | (7.4) | (0.6) |
| Cash From Operations | 64.9 | (5.6) | (41.7) | (19.0) | 9.9 | 7.0 | (12.3) | (12.2) |
| INVESTING CASH FLOW | ||||||||
| Capital Expenditures | (28.3) | (13.6) | (5.6) | (3.5) | (4.8) | (0.9) | (0.3) | (0.5) |
| Other Items | (21.8) | (2.6) | (160.9) | (63.2) | 3 K | 0 | 0 | 0 |
| Cash From Investing Activities | (50.1) | (16.2) | (166.5) | (66.7) | (4.7) | (0.9) | (0.3) | (0.5) |
| FINANCING CASH FLOW | ||||||||
| Common Stock Repurchased | 0 | (5.1) | (1.7) | (0.8) | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 9.9 | (0.1) | (0.1) | 8 K | (27.4) | 20.9 | 5.4 | 8.6 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (3.8) | (2.2) | 1.6 | 5.4 | 3.2 | 1.4 | 10.4 | 0.3 |
| Cash From Financing Activities | 6.1 | (2.3) | 1.5 | 5.4 | 305.9 | 88.3 | 15.8 | 8.9 |
| CHANGE IN CASH | ||||||||
| Net Change In Cash | 20.9 | (24.1) | (206.7) | (80.2) | 311.0 | 94.4 | 3.3 | (3.9) |
| FREE CASH FLOW | ||||||||
| Free Cash Flow | 36.5 | (19.2) | (47.3) | (22.5) | 5.1 | 6.1 | (12.6) | (12.7) |